Parkinson's disease

Neurological diseases

Advancing Parkinson's Disease Research Through Clinical Innovation and Collaboration

At P95 Julius Clinical, we are dedicated to advancing Parkinson’s disease research through scientific expertise, operational excellence, and innovative clinical trial solutions. With deep experience in neuroscience and neurodegenerative diseases, we support the development of novel therapies designed to improve outcomes for people living with Parkinson’s disease.

Our leadership in the field is reflected in our role as the clinical operations partner for The Michael J. Fox Foundation’s Path to Prevention (P2P) platform trial, a groundbreaking international study evaluating investigational therapies in individuals at risk of developing Parkinson’s disease.

Combined with our extensive experience delivering complex neuroscience studies, this work underscores our commitment to helping sponsors, researchers, and patient communities accelerate the development of transformational Parkinson’s therapies.

Download our Parkinson’s Disease Fact Sheet to learn more about our expertise, clinical trial experience, and contributions to advancing Parkinson’s research.

Meet our scientific leader for Parkinson's Disease

Prof. dr. Teus van Laar is Professor of Neurology, Advanced treatment of Parkinson’s Disease, at the UMC Groningen. He is an experienced clinical trialist. In addition he is Director of Parkinon’s Disease Platform Northern Netherlands, Board member of the Dutch Parkinson Scientists and Vice-chair of the Scientific Advisory Board of Parkinson NL.

Meet our scientific leader for Parkinson's Disease

Prif. Fabrizio Stocchi is a Full Professor of Neurology and Director of the Parkinson’s Disease and Movement Disorders Research Center at IRCCS San Raffaele Rome and University “La Sapienza.” Prof. Stocchi’s research focuses on neuropharmacology for movement disorders and neurodegenerative diseases, resulting in numerous publications on Parkinson’s disease. He is also the Scientific Advisor for the Institute for Parkinson’s Disease Research in Vicenza and is a member of several prestigious neurological societies.

Brain Clinical is Julius Clinical’s proprietary network for CNS clinical trials. This network, which covers 13 countries, includes highly experienced and devoted researchers who specialize in streamlined and rigorously executed clinical trials for Parkinson’s Disease treatments.

We’re proud partner of

We work closely with the Brain Research Center in the Netherlands, which specialises in high-quality clinical trial execution for the indications dementia and Parkinson’s Disease.

Read more

Expert team

Conducting intricate clinical studies in Parkinson’s Disease demands a unique blend of scientific acumen and operational precision. At Julius Clinical, we assemble a dedicated team with specialized expertise to navigate the intricacies of Parkinson’s Disease research standards and to effectively orchestrate clinical trials in this dynamic field.

Image of Dr. Lieza G. Exalto
Image of Dr. Nurit Novak

Related webinars

Webinar: The Role of EEG in Dementia Trials
  • Webinars
  • Neurological diseases, Alzheimer's
  • 06-05-2025

Webinar: The Role of EEG in Dementia Trials

How early can you detect whether a treatment is working in dementia trials, and what if you didn’t have to wait for traditional endpoints? Electroencephalography (EEG) is gaining momentum as a powerful tool to capture real-time changes in brain...

More webinars

Parkinson's Disease scientific insights

Explore our Parkinson's Disease trial capabilities, case studies, and other resources.

Download

"*" indicates required fields

*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Share

Twitter Facebook LinkedIn